Walleye Trading’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,139
| Closed | -$146K | – | 5376 |
|
|
2023
Q1 | $101K | Sell |
4,139
-24,599
| -86% | -$539K | ﹤0.01% | 3853 |
|
|
2022
Q4 | $615K | Sell |
28,738
-55,417
| -66% | -$1.18M | ﹤0.01% | 2642 |
|
|
2022
Q3 | $1.51M | Buy |
+84,155
| New | +$1.1M | ﹤0.01% | 1927 |
|
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$27K | – | 5016 |
|
|
2018
Q1 | $27K | Buy |
+10,000
| New | +$29K | ﹤0.01% | 4266 |
|
|
2017
Q4 | – | Sell |
-47,960
| Closed | -$135 | – | 4732 |
|
|
2017
Q3 | $135 | Sell |
47,960
-33,800
| -41% | -$91.3K | ﹤0.01% | 3478 |
|
|
2017
Q2 | $209 | Sell |
81,760
-158,840
| -66% | -$433K | ﹤0.01% | 3081 |
|
|
2017
Q1 | $881 | Buy |
240,600
+106,629
| +80% | +$451K | 0.01% | 1753 |
|
|
2016
Q4 | $647K | Buy |
+133,971
| New | +$3.98M | ﹤0.01% | 1867 |
|
|
2015
Q4 | – | Sell |
-100
| Closed | -$4K | – | 5825 |
|
|
2015
Q3 | $4K | Sell |
100
-200
| -67% | -$10.6K | ﹤0.01% | 4681 |
|
|
2015
Q2 | $16K | Buy |
+300
| New | +$14.9K | ﹤0.01% | 4107 |
|
Walleye Trading's ISEE Position: Q2 2023 in Review
Walleye Trading sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 4,139 shares — an estimated $146K sold.
Walleye Trading first reported a position in ISEE in Q2 2015 and held it in 10 quarters. The position peaked at $1.51M in Q3 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.
- Walleye Trading reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Walleye Trading sold 4,139 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $146K.
- Walleye Trading first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 10 quarters.
- Walleye Trading's IVERIC bio, Inc. Common Stock position peaked at $1.51M in Q3 2022.
- 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.
Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.